The Neutralizing Face of Hepatitis C Virus E2 Envelope Glycoprotein
The high genetic variability of hepatitis C virus, together with the high level of glycosylation on the viral envelope proteins shielding potential neutralizing epitopes, pose a difficult challenge for vaccine development. An effective hepatitis C virus (HCV) vaccine must target conserved epitopes a...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008530/ https://www.ncbi.nlm.nih.gov/pubmed/29951061 http://dx.doi.org/10.3389/fimmu.2018.01315 |